A survey of techniques to reduce and manage external beam radiation-induced xerostomia in British oncology and radiotherapy departments

Radiography

Volumn 15, Issue 4, 2009, Pages 283-291

  Macknelly, Andrew ^a   Day, Jane ^b  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SUFFOLK   (United Kingdom)

Author keywords

Amifostine; Dental care; Dietary care; Dry mouth; Head and neck cancer; Pilocarpine

Indexed keywords

AMIFOSTINE; PILOCARPINE;

ALTERNATIVE MEDICINE; ARTICLE; CLINICAL PROTOCOL; COMPUTER ASSISTED RADIOTHERAPY; DENTAL CARE; EXTERNAL BEAM RADIOTHERAPY; HEAD AND NECK CANCER; HEALTH SURVEY; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; RADIATION DOSE; RADIOLOGY DEPARTMENT; SALIVARY GLAND; SEMI STRUCTURED INTERVIEW; XEROSTOMIA;

EID: 70349499463     PISSN: 10788174     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radi.2009.01.002     Document Type: Article

References (30)

1. In: Hanks P. (Ed). Collins english dictionary (1985), Collins, London
2. Anand A., Jain J., Negi P., Chaudhoory A., Sinha S., Choudhury P., et al. Can dose reduction to one parotid gland prevent xerostomia? - A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy. Clinical Oncology 18 6 (2006) 497-504
3. Berk L., Shivnani A., and Small W. Pathophysiology and management of radiation-induced xerostomia. Journal of Supportive Oncology 3 3 (2005) 191-200
4. Wells M. Oropharyngeal effects of radiotherapy. In: Faithfull S., and Wells M. (Eds). Supportive care in radiotherapy (2003), Churchill Livingstone, Edinburgh
5. Patt R., and Lang S. The complete guide to relieving cancer pain and suffering (2004), Oxford University Press, Oxford
6. Joint Formulary Committee. British national formulary 51 (2006), British Medical Association and Royal Pharmaceutical Society of Great Britain, London
7. Braam P., Terhaard C., Roesnink J., Cornelis P., and Raaijmakers C. Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy. International Journal of Radiation Oncology, Biology and Physics (2006)
8. Wendt T.G., Abbasi-Senger N., Salz H., Pinquart I., Koscelny S., Przetak S., et al. 3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing. Radiation Oncology 1 (2006) 18. http://www.ro-journal.com/content/1/1/18 [accessed on 21.11.06]
9. Ng M., Porceddu S., Milner A., Corry J., Hornby C., Hope G., et al. Parotid-sparing radiotherapy: does it really reduce xerostomia?. Clinical Oncology 17 8 (2005) 610-617
10. Eisbruch A., Ten Haken R., Kim H., Marsh L., and Ship J. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity modulated irradiation of head and neck cancer. International Journal of Radiation Oncology, Biology and Physics 45 3 (1999) 577-587
11. British Columbia Cancer Agency. Amifostine. 2006. Available from: http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/amifostine.htm [accessed 20.02.07].
12. Brizel D., Wasserman T., Henke M., Strnad V., Rudat V., Monnier A., et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. Journal of Clinical Oncology 18 19 (2000) 3339-3345
13. Antonadou D., Pepelassi M., Synodinou M., Puglisi M., and Throuvalas N. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head and neck cancer. International Journal of Radiation Oncology, Biology and Physics 52 3 (2002) 739-747
14. Hodson D, Browman G, Thephamongkhol K, Oliver T, Zuraw L. The role of amifostine as a radioprotectant in the management of patients with squamous cell head and neck cancer. 2004. Available from: http://www.cancercare.on.ca/pdf/pebc5-8f.pdf [accessed 20.02.07].
15. Koukourakis M., and Danielidis V. Preventing radiation-induced xerostomia. Cancer Treatment Reviews 31 7 (2005) 546-554
16. Gosselin T., Raj K., Clough R., and Brizel D. Amifostine for xerostomia - normal tissue protection at what cost?. International Journal of Radiation Oncology, Biology and Physics (Supplement) 63 2 (2005) S128
17. Lindegaard C., and Grau C. Has the outlook improved for amifostine as a clinical radioprotector?. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 57 2 (2000) 113-118
18. Lu W. Acupuncture for side effects of chemoradiation therapy in cancer patients. Seminars in Oncology Nursing 21 3 (2005) 190-195
19. Jedel E. Acupuncture in xerostomia, a systematic review. Journal of Oral Rehabilitation 32 6 (2005) 392-396
20. The Columbia electronic encyclopaedia. 2005. Available from: http://columbia.thefreedictionary.com/pilocarpine [accessed 20.02.07].
21. Haddad P., and Karimi M. A randomised, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia. Radiotherapy and Oncology 64 1 (2002) 29-32
22. Bartels C. Helping patients with dry mouth. 2007. Available from: http://www.oralcancerfoundation.org/dental/xerostomia.htm [accessed 02.02.07].
23. Society and College of Radiographers. Contact details for departments of radiotherapy and clinical oncology in the United Kingdom (2006), College of Radiographers, London.
24. Parahoo K. Nursing research, principles, process and issues. 2nd ed. (2006), Palgrave Macmillan, Basingstoke
25. National Institute for Clinical Health and Excellence (NICE). Improving outcomes in head and neck cancers: the manual (2004), Office of Public Sector Information, London
26. Bomford C., and Kunkler I. Walter and Miller's textbook of radiotherapy. 6th ed. (2003), Churchill Livingstone, Edinburgh
27. Cancer Research UK. 2006. Available from: http://www.cancerhelp.org.uk/help/default.asp?page=10427 [accessed 02.02.07].
28. Department of Health. The NHS cancer plan, a plan for investment, a plan for reform (2000), Department of Health, London
29. The Institute of Cancer Research. PARSPORT. 2006. Available from: http://www.icr.ac.uk/research/research_sections/clinical_trials/clinical_trials_list/2380_disease.shtml [accessed 23.12.06].
30. Bourn J. The NHS cancer plan: a progress report (2005), National Audit Office, London